SG123894G - Novel dosage form - Google Patents

Novel dosage form

Info

Publication number
SG123894G
SG123894G SG123894A SG123894A SG123894G SG 123894 G SG123894 G SG 123894G SG 123894 A SG123894 A SG 123894A SG 123894 A SG123894 A SG 123894A SG 123894 G SG123894 G SG 123894G
Authority
SG
Singapore
Prior art keywords
dosage form
novel dosage
novel
dosage
Prior art date
Application number
SG123894A
Other languages
English (en)
Inventor
Karin Malmqvist-Granlund
Christer Hermansson
Soeren Kulstad
Original Assignee
Dib Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to SE19888803822A priority Critical patent/SE8803822D0/xx
Priority to EP89119102A priority patent/EP0365947B1/fr
Priority to DE89119102T priority patent/DE68907177T2/de
Priority to ES89119102T priority patent/ES2055775T3/es
Priority to CA002000932A priority patent/CA2000932C/fr
Priority to AU43650/89A priority patent/AU612525B2/en
Priority to JP1276203A priority patent/JPH082783B2/ja
Priority to US07/770,767 priority patent/US5178868A/en
Application filed by Dib Ltd filed Critical Dib Ltd
Priority to SG123894A priority patent/SG123894G/en
Priority to HK123394A priority patent/HK123394A/xx
Publication of SG123894G publication Critical patent/SG123894G/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG123894A 1988-10-26 1994-08-25 Novel dosage form SG123894G (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE19888803822A SE8803822D0 (sv) 1988-10-26 1988-10-26 Novel dosage form
EP89119102A EP0365947B1 (fr) 1988-10-26 1989-10-14 Forme de dosage
DE89119102T DE68907177T2 (de) 1988-10-26 1989-10-14 Dosierungsform.
ES89119102T ES2055775T3 (es) 1988-10-26 1989-10-14 Nueva forma de dosificacion.
CA002000932A CA2000932C (fr) 1988-10-26 1989-10-18 Forme pharmaceutique orale multiparticulaire a liberation controlee
AU43650/89A AU612525B2 (en) 1988-10-26 1989-10-24 Novel dosage form
JP1276203A JPH082783B2 (ja) 1988-10-26 1989-10-25 新規な投与形態
US07/770,767 US5178868A (en) 1988-10-26 1991-10-04 Dosage form
SG123894A SG123894G (en) 1988-10-26 1994-08-25 Novel dosage form
HK123394A HK123394A (en) 1988-10-26 1994-11-10 Novel dosage form

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19888803822A SE8803822D0 (sv) 1988-10-26 1988-10-26 Novel dosage form
SG123894A SG123894G (en) 1988-10-26 1994-08-25 Novel dosage form

Publications (1)

Publication Number Publication Date
SG123894G true SG123894G (en) 1995-03-17

Family

ID=26660328

Family Applications (1)

Application Number Title Priority Date Filing Date
SG123894A SG123894G (en) 1988-10-26 1994-08-25 Novel dosage form

Country Status (9)

Country Link
EP (1) EP0365947B1 (fr)
JP (1) JPH082783B2 (fr)
AU (1) AU612525B2 (fr)
CA (1) CA2000932C (fr)
DE (1) DE68907177T2 (fr)
ES (1) ES2055775T3 (fr)
HK (1) HK123394A (fr)
SE (1) SE8803822D0 (fr)
SG (1) SG123894G (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9202250D0 (sv) * 1992-07-29 1992-07-29 Gacell Lab Ab Controlled release morphine preparation
US6875872B1 (en) 1993-05-28 2005-04-05 Astrazeneca Compounds
US5817338A (en) * 1994-07-08 1998-10-06 Astra Aktiebolag Multiple unit tableted dosage form of omeprazole
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
SE9600072D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
US6066339A (en) * 1997-10-17 2000-05-23 Elan Corporation, Plc Oral morphine multiparticulate formulation
US6962717B1 (en) * 1999-01-29 2005-11-08 Disphar International B.V. Pharmaceutical compositions
SE0001151D0 (sv) * 2000-03-31 2000-03-31 Amarin Dev Ab Method for producing a controlled-release composition
DE10149674A1 (de) 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
PT1448235E (pt) * 2001-11-30 2007-05-31 Pfizer Prod Inc Composições farmacêuticas orais de libertação controlada de 5,8,14-triazatetraciclo ( 10.3.1.0(2,11).0(4,9) ) - hexadeca-2(11),3,5,7,9-pentaeno.
JP2005104914A (ja) * 2003-09-30 2005-04-21 Kyowa Yakuhin Kogyo Kk 塩基性薬剤含有製剤
WO2007123883A2 (fr) * 2006-04-17 2007-11-01 Actavis Group Ptc Ehf Formes posologiques orales et méthodes de préparation de celles-ci

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
DE3486409T2 (de) * 1984-08-17 1996-04-25 Wellcome Found Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs.
SE8404467D0 (sv) * 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules

Also Published As

Publication number Publication date
AU4365089A (en) 1990-05-03
AU612525B2 (en) 1991-07-11
HK123394A (en) 1994-11-18
SE8803822D0 (sv) 1988-10-26
ES2055775T3 (es) 1994-09-01
EP0365947B1 (fr) 1993-06-16
CA2000932C (fr) 1999-12-28
DE68907177T2 (de) 1994-01-13
EP0365947A1 (fr) 1990-05-02
CA2000932A1 (fr) 1990-04-26
JPH02164821A (ja) 1990-06-25
DE68907177D1 (de) 1993-07-22
JPH082783B2 (ja) 1996-01-17

Similar Documents

Publication Publication Date Title
GB2210266B (en) Dosage form
EP0344476A3 (en) Ampoule
AU3313889A (en) Novel unit dosage form
ZA895838B (en) Pharmaceutical compounds
SG123894G (en) Novel dosage form
ZA89260B (en) Pharmaceutical compounds
GB8825892D0 (en) Pharmaceutical composition
IL92508A0 (en) Novel alpha-cyano-beta-oxopropionamides
ZA893422B (en) Pharmaceutical composition
GB8607178D0 (en) Dosage means
EP0443027A4 (en) Drug composition
GB8708225D0 (en) Dosage form
GB8802226D0 (en) Improved trackerball
GB8807505D0 (en) Pharmaceutical combinations
KR0120111B1 (en) Novel dosage form
DE3990515D2 (en) 2-komponenten-bindemittel
GB8823568D0 (en) Novel pharmaceutical use
GB8826204D0 (en) Pharmaceutical compounds
GB8830078D0 (en) Pharmaceutical compounds
GB8818098D0 (en) Pharmaceutical composition
GB8802927D0 (en) Pharmaceutical composition
GB8818118D0 (en) Pharmaceutical composition
GB8807384D0 (en) Pharmaceutical composition
GB8827718D0 (en) Pharmaceutical composition
GB8802926D0 (en) Pharmaceutical composition